While the “obesity paradox” was initially observed, it became much less pronounced after accounting for insulin treatment and completely disappeared in patients with poorly controlled glycemia (HbA1C percentage > 7.5%) [37]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.